Characteristics of the early stages of intravenous bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer

References

• Watts NB. Treatment of osteoporosis with bisphosphonates. Endocrinol Methab Clin North Am 1998;27:419–39.
   PubMed Web of Science ®Google Scholar
• Berenson JR, Rosen LS, Howell A, Porter L, Coleman RE, Morley W, et al. Zoledronic acid reduces skeletal-related events in patients with osteolytic metastasis. Cancer 2001;91:1191–200.
   PubMed Web of Science ®Google Scholar
• American Association of Oral and Maxillofacial Surgeons. Position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007;65:369–76.
   PubMed Web of Science ®Google Scholar
• Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007;22:1479–91.
   PubMed Web of Science ®Google Scholar
• Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, et al. Bisphosphonate-related osteonecrosis of the jaw: position paper from the allied task force committee of the Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons. J Bone Miner Metab 2010;28:365–83.
   PubMed Web of Science ®Google Scholar
• Khan AA, Sándor GK, Dore E, Morrison AD, Alsahli M, Amin F, et al. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 2008;35:1391–7.
   PubMed Web of Science ®Google Scholar
• Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates. A review of 63 cases. J Oral Maxillofac Surg 2004;62:527–34.
   PubMed Web of Science ®Google Scholar
• Van den Wyngaert T, Claeys T, Huizing M, Vermorken JB, Fossion E. Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. Ann Oncol 2009;20:331–6.
   PubMed Web of Science ®Google Scholar
• Fedele S, Porter SR, D’Aiuto F, Aljohani S, Vescovi P, Manfredi M, et al. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. Am J Med 2011;123:1060–4.
   Web of Science ®Google Scholar
• Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons: American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws - 2009 update. J Oral Maxillofac Surg 2009;67:2–12.
   PubMed Web of Science ®Google Scholar
• Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the Jaws in Australia. J Oral Maxillofac Surg 2007;65:415–23.
   PubMed Web of Science ®Google Scholar
• Oken MM, Creech RH, Tormey DC. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 1982;5:649–55.
   PubMed Web of Science ®Google Scholar
• Hess LM, Jeter JM, Benham-Hutchins M, Alberts DS. Factors associated with osteonecrosis of the jaw among bisphosphonate users. Am J Med 2008;121:475–83.
   PubMed Web of Science ®Google Scholar
• Silverman SL, Landesberg R. Osteonecrosis of the jaw and the role of bisphosphonates: a critical review. Am J Med 2009;122:S33–45.
   PubMed Web of Science ®Google Scholar
• Bagan JV, Jimenez Y, Diaz JM, Murillo J, Sanchis JM, Poveda R, et al. Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification. Oral Oncol 2009;45:645–6.
   PubMed Web of Science ®Google Scholar
• Mawardi H, Treister N, Richardson P, Anderson K, Munshi N, Faiella RA, et al. Sinus tracts an early sign of bisphosphonate-associated osteonecrosis of the jaws? J Oral Maxillofac Surg 2009;67:593–601.
   PubMed Web of Science ®Google Scholar
• Junquera L, Gallego L. Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant? J Oral Maxillofac Surg 2008;66:1516–17.
   PubMed Web of Science ®Google Scholar
• Hutchinson M, O’Ryan F, Chavez V, Lathon PV, Sanchez G, Hatcher DC, et al. Radiographic findings in bisphosphonate treated patients with stage 0 disease in the absence of bone exposure. J Oral Maxillofac Surg 2010;68:2232–40.
   PubMed Web of Science ®Google Scholar
• Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M, et al. Frequency and risk factors associated with osteonecrosis of the Jaw in cancer patients treated with intravenous bisphosphonate. J Bone Miner Res 2008;23:826–36.
   PubMed Web of Science ®Google Scholar
• Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 2005;23:8580–7.
   PubMed Web of Science ®Google Scholar
• Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, et al. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol 2009;27:5356–62.
   PubMed Web of Science ®Google Scholar
• Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 2005;353:99–102.
   PubMed Web of Science ®Google Scholar
• Vescovi P, Campisi G, Fusco V, Mergoni G, Manfredi M, Merigo E, et al. Surgery-triggered and non surgery-triggered bisphosphonate-related osteonecrosis of the Jaws (BRONJ): a retrospective analysis of 567 cases in an Italian multicenter study. Oral Oncol 2011;47:191–4.
   PubMed Web of Science ®Google Scholar
• Ficarra G, Beninati F, Rubino I, Vannucchi A, Longo G, Tonelli P, et al. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 2005;32:1123–8.
   PubMed Web of Science ®Google Scholar
• Bilezikian JP. Osteonecrosis of the jaw. Do bisphosphonates pose a risk? N Engl J Med 2006;355:2278–81.
   PubMed Web of Science ®Google Scholar
• Aghaloo TL, Kang B, Sung EC, Shoff M, Ronconi M, Gotcher JE, et al. Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. J Bone Miner Res 2011;26:1871–82.
   PubMed Web of Science ®Google Scholar
• Saia G, Blandamura S, Bettini G, Tronchet A, Totola A, Bedogni G, et al. Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction. J Oral Maxillofac Surg 2010;68:797–804.
   PubMed Web of Science ®Google Scholar
• Bedogni A, Blandamura S, Lokmic Z, Palumbo C, Ragazzo M, Ferrari F, et al. Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:358–64.
   PubMed Web of Science ®Google Scholar
• Trister N, Sheehy N, Bae EH, Friedland B, Lerman M, Woo S. Dental panoramic radiographic evaluation in bisphosphonate-associated osteonecrosis of the jaws. Oral Dis 2009;15:88–92.
   PubMed Web of Science ®Google Scholar
• Bianchi SD, Scoletta M, Cassione FB, Migliaretti G, Mozzati M. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104:249–58.
   PubMed Web of Science ®Google Scholar
• Komatsuobara S, Mori S, Mashiba T, Ito M, Li J, Kaji Y, et al. Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra. J Bone Miner Res 2003;18:512–20.
   PubMed Web of Science ®Google Scholar
• Shahnazari M, Yao W, Dai W, Wang B, Ionova-Martin SS, Ritchie RO, et al. Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats. Bone 2010;46:1267–74.
   PubMed Web of Science ®Google Scholar
• Walter C, Al-Nawas B, du Bois A, Buch L, Halter P, Grotz KA. Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients. Cancer 2009;115:1631–7.
   PubMed Web of Science ®Google Scholar
• Aguiar Bujanda D, Bohn Sarmiento U, Cabrera Suarez MA, Aguiar Morales J. Assessment of renal toxicity and osteonecrosis of the jaw in patients receiving zoledronic acid for bone metastases. Ann Oncol 2007;18:556–60.
   PubMed Web of Science ®Google Scholar
• Ibrahim T, Barbanti F, Marrano GG, Mercatali L, Ronconi S, Vicini C, et al. Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: a retrospective study. Oncologist 2008;13:330–6.
   PubMed Web of Science ®Google Scholar
• Sanna G, Preda L, Bruschini R, Cossu Rocca M, Ferretti S, Adamoli L, et al. Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer. Ann Oncol 2006;17:1512–16.
   PubMed Web of Science ®Google Scholar
• Wang EP, Kaban LB, Strewler GJ, Noopur R, Troulis MJ. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. J Oral Maxillofac Surg 2007;65:1328–31.
   PubMed Web of Science ®Google Scholar
• Ripamonti CI, Maniezzo M, Campa T, Fagnoni E, Brunelli C, Saibene G, et al. Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the national cancer institute of Milan. Ann Oncol 2009;20:137–45.
   PubMed Web of Science ®Google Scholar
• Dimopoulos MA, Kastritis E, Bamia C, Melakopoulos I, Gika D, Roussou M, et al. Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol 2009;20:117–20.
   PubMed Web of Science ®Google Scholar
• Bedogni A, Saia G, Bettini G, Tronchet A, Totola A, Bedogni G, et al. Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis. Oral Oncol 2011;417:420–4.
   Google Scholar
• Carlson ER, Basile JD. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2009;67:85–95.
   PubMed Web of Science ®Google Scholar
• Williamson RA. Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg 2010;39:251–5.
   PubMed Web of Science ®Google Scholar
• Abu-Id MH, Warnke PH, Gottschalk J, Springer I, Wiltfang J, Acil Y, et al. “Bisphossy jaws” - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw. J Cranio Maxillofac Surg 2008;36:95–103.
   PubMed Web of Science ®Google Scholar
• Coleman RE. Skeletal complications of malignancy. Cancer 1997;80(Suppl):1588–94.
   PubMed Web of Science ®Google Scholar
• Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A, et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 2006;24:945–52.
   PubMed Web of Science ®Google Scholar
• Quispe D, Shi R, Burton G. Osteonecrosis of the jaw in patients with metastatic breast cancer: ethnic and socio-economic aspects. Breast J 2011;17:510–13.
   PubMed Web of Science ®Google Scholar